Ely D. Tendler - Oct 2, 2023 Form 4 Insider Report for DocGo Inc. (DCGO)

Role
General Counsel and Secretary, Director
Signature
/s/ Ely D. Tendler
Stock symbol
DCGO
Transactions as of
Oct 2, 2023
Transactions value $
-$37,000
Form type
4
Date filed
10/4/2023, 05:32 PM
Previous filing
Sep 19, 2023
Next filing
Dec 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCGO Common Stock Options Exercise $15.9K +10K +43.31% $1.59 33.1K Oct 2, 2023 Direct F1, F2
transaction DCGO Common Stock Sale -$52.9K -10K -30.22% $5.29 23.1K Oct 2, 2023 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DCGO Options to purchase Common Stock Options Exercise $0 -10K -77.51% $0.00 2.9K Oct 2, 2023 Common Stock 10K $1.59 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Exercise of options effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023 (the "10b5-1 Plan").
F2 Reflects 23,088 restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan"), which will vest on December 15, 2023. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.
F3 Sale of shares effected pursuant to the 10b5-1 Plan.
F4 The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $5.19 to $5.39. Upon request from the staff of the U.S. Securities and Exchange Commission, the Issuer or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F5 The options vested in three equal annual installments beginning on November 12, 2020 and expire January 1, 2030, subject to the terms of the Option Agreement entered into with Ambulnz Inc. and assumed by the Issuer on November 5, 2021.